Objective:

To report the feasibility and outcomes of converting to RefluxStop after failed antireflux surgery (ARS) and discuss surgical considerations of conversion.

Approach:

Key Findings:

• Most subjects (53.3%) were female, with a median age of 55 years and median BMI of 26.9 kg/m2.
• 86.7% of patients had hiatal hernia (HH) at baseline, with 33.3% having HH ≥4 cm.
• 93.3% of subjects were on PPI therapy post-ARS, with 86.7% experiencing persistent symptoms before RefluxStop.

Interpretation:

RefluxStop may be a feasible option for patients with persistent GERD symptoms after failed ARS, showing potential for improved outcomes.

Limitations:

• The study is limited by its retrospective design and small sample size.
• Data was collected from two centers, which may affect generalizability.

Conclusion:

RefluxStop surgery may provide a suitable alternative for patients with failed ARS, offering a novel approach to managing GERD.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.